| FNGR 0.398 129.53% | CHAI 0.4 57.11% | LGCL 0.0389 -27.02% | CYAB 0.4467 45.36% | NVDA 217.55 -4.57% | CHGA 2.852 2,082.10% | PCG 16.6 -7.52% | NCPL 0.6916 28.41% | NVD 4.05 8.58% | BITO 10.45 -3.06% | IREN 35.45 -12.53% | INTC 89.47 -2.85% | NU 14.3 -3.90% | IBIT 43.9 -3.07% | XTNT 0.384 16.36% | TSLL 8.98 -3.54% | ONDS 7.9 -9.71% | DUO 0.9602 37.56% | AAL 13.64 -0.58% | SOAR 0.2169 5.80% | SOXL 111.34 -9.52% | BTAI 0.1814 -74.76% | TQQQ 71.85 -1.98% | ETHA 18.37 -2.65% | FTFT 2.2188 281.50% | SPCX 141.5 0.45% | PATH 18.15 -0.98% | BMNR 23.8 -7.14% | NOK 10.21 -3.59% | AMZN 266.43 3.97% | MRVL 216.62 -10.28% | SOXS 49.82 9.86% | WHLR 1.07 -4.46% | SQQQ 38.54 2.03% | PLUG 2.19 -3.52% | SOFI 18.06 -5.84% | AEMD 2.49 14.75% | SPDN 8.49 0.12% | QID 14.24 1.42% | MARA 10.67 -10.11% | KEEL 3.23 -7.98% | GDX 99.65 -3.90% | RIVN 16.07 -4.35% | F 13.87 -0.57% | BTG 5.66 -2.92% | AAPL 319.7 1.63% | PURR 11.61 -9.51% | SMR 9.29 -4.62% | VALE 15.03 -1.83% | SPY 769.35 -0.23%

DocuSign Reinitiated at Underperform by BofA on Growth Uncertainty

BofA Securities reinstated coverage of DocuSign Inc. (NASDAQ: DOCU) with an Underperform rating and a $52 price target, citing uncertainty around its growth trajectory.

The firm noted that while DocuSign has historically dominated the eSignature market, the segment is now approaching maturity and becoming increasingly commoditized. As a result, the company’s revenue growth has plateaued in the high single-digit range over the past ten quarters.

Against this backdrop, DocuSign is shifting its focus toward becoming a comprehensive agreement management platform. However, BofA highlighted increasing competition from artificial intelligence companies such as OpenAI and Anthropic, which are entering the market with document-focused AI tools.

While the firm acknowledged that DocuSign has the foundational elements to establish itself in intelligent agreement management, it said a clear inflection point in growth is not yet visible.

Given these factors, BofA sees limited near-term upside for the stock, even though it is trading at a discounted valuation.

Published on: March 31, 2026